Gianluca Bottoni
Overview
Explore the profile of Gianluca Bottoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piccardo A, Bottoni G, Treglia G, Foppiani L, Mariani F, Catrambone U, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39998675
Purpose: Accurate initial staging of differentiated thyroid carcinoma (DTC) is paramount to avoid disease persistence or relapses. Neck ultrasound (US) is the gold-standard examination for lymph node staging; however, it...
2.
Piccardo A, Fiz F, Righi S, Raffa S, Riondato M, Bottoni G, et al.
Eur Thyroid J
. 2025 Jan;
14(1).
PMID: 39792974
Background: In relapsing differentiated thyroid cancer (DTC), the in vivo evaluation of natrium-iodide symporter (NIS) expression is pivotal in the therapeutic planning and is achieved by 131/123Iodine (131/123I) whole body...
3.
Mureddu M, Funck T, Morana G, Rossi A, Ramaglia A, Milanaccio C, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458202
: PET imaging with [F]F-DOPA has demonstrated high potential for the evaluation and management of pediatric brain gliomas. Manual extraction of PET parameters is time-consuming, lacks reproducibility, and varies with...
4.
Albano D, Piccardo A, Rizzo A, Cuzzocrea M, Bottoni G, Bellini P, et al.
Endocrine
. 2024 Sep;
87(2):351-361.
PMID: 39249633
Purpose: This updated systematic review and bivariate meta-analysis aimed to investigate the diagnostic performance of 2-[F]FDG PET/CT for the detection of recurrent disease in patients with differentiated thyroid cancer (DTC)...
5.
Piccardo A, Bottoni G, Puppo C, Massollo M, Ugolini M, Naseri M, et al.
J Nucl Med
. 2024 Jul;
65(9):1357-1363.
PMID: 39054284
Molecular imaging of muscle-invasive bladder cancer (MBC) is restricted to its locoregional and distant metastases, since most radiopharmaceuticals have a urinary excretion that limits the visualization of the primary tumor....
6.
Fiz F, Piticchio T, Bottoni G, Sorrentino S, Fragola M, Livellara V, et al.
Q J Nucl Med Mol Imaging
. 2024 Feb;
68(1):40-47.
PMID: 38319674
Introduction: Treatment with [I]mIBG is commonly used in pediatric metastatic neuroblastoma (NB); however, unbound [I]I might be taken up by the thyroid, causing hypothyroidism. To prevent this occurrence, thyroid blockade...
7.
Fiz F, Cirone A, Righi S, Massollo M, Amoroso L, Bottoni G, et al.
Pediatr Blood Cancer
. 2023 Dec;
71(3):e30806.
PMID: 38082548
Background: I-metaiodobenzylguanidine ( I-mIBG) effectiveness in children with metastasised neuroblastoma (NB) is linked to the effective dose absorbed by the target; a target of 4 Gy whole-body dose threshold has...
8.
Piccardo A, Treglia G, Fiz F, Bar-Sever Z, Bottoni G, Biassoni L, et al.
Eur J Nucl Med Mol Imaging
. 2023 Nov;
51(3):756-767.
PMID: 37962616
Background: Molecular imaging is pivotal in staging and response assessment of children with neuroblastoma (NB). [I]-metaiodobenzylguanidine (mIBG) is the standard imaging method; however, it is characterised by low spatial resolution,...
9.
Foppiani L, Fiz F, Dezzana M, Massollo M, Bottoni G, Piccardo A
Rev Esp Med Nucl Imagen Mol (Engl Ed)
. 2023 Nov;
43(1):61-62.
PMID: 37923215
No abstract available.
10.
Cistaro A, Quartuccio N, Piccardo A, Meo G, Gandoglia I, Schiera I, et al.
Nucl Med Commun
. 2023 Oct;
44(12):1163-1167.
PMID: 37779439
Aim: Patients with idiopathic normal-pressure hydrocephalus (iNPH) can show a global reduction in cerebral glucose metabolism at [ 18 F]Fluorodeoxyglucose (FDG) PET. The presence of caudate hypometabolism has been identified...